Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Status:
Completed
Trial end date:
2017-12-06
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate whether bicalutamide given in
combination with anastrozole once daily for 12 months is effective in treating testotoxicosis
in boys. Testotoxicosis is a condition that causes early puberty in boys including growth in
height, and development of muscles and sexual organs .